In vivo bioassay to test the pathogenicity of missense human AIP variants
- PMID: 29632148
- PMCID: PMC6073908
- DOI: 10.1136/jmedgenet-2017-105191
In vivo bioassay to test the pathogenicity of missense human AIP variants
Abstract
Background: Heterozygous germline loss-of-function mutations in the aryl hydrocarbon receptor-interacting protein gene (AIP) predispose to childhood-onset pituitary tumours. The pathogenicity of missense variants may pose difficulties for genetic counselling and family follow-up.
Objective: To develop an in vivo system to test the pathogenicity of human AIP mutations using the fruit fly Drosophila melanogaster.
Methods: We generated a null mutant of the Drosophila AIP orthologue, CG1847, a gene located on the Xchromosome, which displayed lethality at larval stage in hemizygous knockout male mutants (CG1847exon1_3 ). We tested human missense variants of 'unknown significance', with 'pathogenic' variants as positive control.
Results: We found that human AIP can functionally substitute for CG1847, as heterologous overexpression of human AIP rescued male CG1847exon1_3 lethality, while a truncated version of AIP did not restore viability. Flies harbouring patient-specific missense AIP variants (p.C238Y, p.I13N, p.W73R and p.G272D) failed to rescue CG1847exon1_3 mutants, while seven variants (p.R16H, p.Q164R, p.E293V, p.A299V, p.R304Q, p.R314W and p.R325Q) showed rescue, supporting a non-pathogenic role for these latter variants corresponding to prevalence and clinical data.
Conclusion: Our in vivo model represents a valuable tool to characterise putative disease-causing human AIP variants and assist the genetic counselling and management of families carrying AIP variants.
Keywords: AIP; FIPA; drosophila melanogaster; pathogenic genetic variant; pituitary adenoma.
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Conflict of interest statement
Competing interests: None declared.
Figures




Similar articles
-
Reassessing the role of the p.(Arg304Gln) missense AIP variant in pituitary tumorigenesis.Eur J Endocrinol. 2025 Mar 27;192(4):385-397. doi: 10.1093/ejendo/lvaf044. Eur J Endocrinol. 2025. PMID: 40070360 Free PMC article.
-
Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families.Hum Mutat. 2010 Aug;31(8):950-60. doi: 10.1002/humu.21292. Hum Mutat. 2010. PMID: 20506337 Free PMC article.
-
Screening for AIP gene mutations in a Han Chinese pituitary adenoma cohort followed by LOH analysis.Eur J Endocrinol. 2013 Oct 23;169(6):867-84. doi: 10.1530/EJE-13-0442. Print 2013 Dec. Eur J Endocrinol. 2013. PMID: 24050928
-
Mutations of the gene for the aryl hydrocarbon receptor-interacting protein in pituitary adenomas.Horm Res. 2009;71(3):132-41. doi: 10.1159/000197869. Epub 2009 Feb 3. Horm Res. 2009. PMID: 19188737 Review.
-
AIP mutations and gigantism.Ann Endocrinol (Paris). 2017 Jun;78(2):123-130. doi: 10.1016/j.ando.2017.04.012. Epub 2017 May 5. Ann Endocrinol (Paris). 2017. PMID: 28483363 Review.
Cited by
-
The clinical and therapeutic profiles of prolactinomas associated with germline pathogenic variants in the aryl hydrocarbon receptor interacting protein (AIP) gene.Front Endocrinol (Lausanne). 2023 Aug 29;14:1242588. doi: 10.3389/fendo.2023.1242588. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37711900 Free PMC article.
-
A scalable Drosophila assay for clinical interpretation of human PTEN variants in suppression of PI3K/AKT induced cellular proliferation.PLoS Genet. 2021 Sep 7;17(9):e1009774. doi: 10.1371/journal.pgen.1009774. eCollection 2021 Sep. PLoS Genet. 2021. PMID: 34492006 Free PMC article.
-
RET signalling provides tumorigenic mechanism and tissue specificity for AIP-related somatotrophinomas.Oncogene. 2021 Nov;40(45):6354-6368. doi: 10.1038/s41388-021-02009-8. Epub 2021 Sep 29. Oncogene. 2021. PMID: 34588620 Free PMC article.
-
Genetics of Acromegaly and Gigantism.J Clin Med. 2021 Mar 29;10(7):1377. doi: 10.3390/jcm10071377. J Clin Med. 2021. PMID: 33805450 Free PMC article. Review.
-
AIP gene germline variants in adult Polish patients with apparently sporadic pituitary macroadenomas.Front Endocrinol (Lausanne). 2023 Feb 10;14:1098367. doi: 10.3389/fendo.2023.1098367. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36843582 Free PMC article.
References
-
- Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TM, Salmela PI, Paschke R, Gündogdu S, De Menis E, Mäkinen MJ, Launonen V, Karhu A, Aaltonen LA. Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 2006;312:1228–30. 10.1126/science.1126100 - DOI - PubMed
-
- Hernández-Ramírez LC, Gabrovska P, Dénes J, Stals K, Trivellin G, Tilley D, Ferrau F, Evanson J, Ellard S, Grossman AB, Roncaroli F, Gadelha MR, Korbonits M. International FIPA Consortium. Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers. J Clin Endocrinol Metab 2015;100:E1242–54. 10.1210/jc.2015-1869 - DOI - PMC - PubMed
-
- Hernández-Ramírez LC, Martucci F, Morgan RM, Trivellin G, Tilley D, Ramos-Guajardo N, Iacovazzo D, D’Acquisto F, Prodromou C, Korbonits M. Rapid Proteasomal Degradation of Mutant Proteins Is the Primary Mechanism Leading to Tumorigenesis in Patients With Missense AIP Mutations. J Clin Endocrinol Metab 2016;101:3144–54. 10.1210/jc.2016-1307 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous